TAVR-in-TAVR procedure on a patient with cardiogenic shock due to a degenerated corevalve

While Transcatheter Aortic Valve Replacement (TAVR) has expanded accept changas a treatment for symptomatic aortic valve stenosis, little is known about its long-term outcomes. We present a 92-years-old female presenting with cardiogenic shock due to an 8-years-old degenerated transcatheter heart valve submitted to life-saving balloon valvuloplasty and redo TAVR.